Maria Elisa Mancuso: During Day 2 of the Annual EHC Conference We Discussed Very Rare Bleeding Disorders!
Maria Elisa Mancuso, Senior Hematology Consultant at Humanitas Research Hospital, shared on LinkedIn:
”During Day 2 of the Annual EHC Conference in Vienna we discussed very rare bleeding disorders as fibrinogen defects (thanks to Alessandro Casini) and the “newly recognized” group of Bleeding Disorders of Unknown Cause – BDUC (thanks to Johanna Gebhart).
Congratulations to Dominik Cepic for is wonderful overview and passionate advocacy for hemophilia B with inhibitors as “rare among rares”.
The SLAM session shed lights to many important issues as orthopedic evaluation and care of arthropathy, treatment of PUPs, pain and ITI.
During the session dedicated to gene therapy real world experience (Wolfgang Miesbach), struggles in procurement and reimbursement (Gaetan Duport) and new non-AAV mediated gene therapies (Paul Batty) were discussed.
Finally the day was beautifully close by the energy of the youth debates.”
More from EHC 2025 featured in Hemostasis Today.
-
Oct 5, 2025, 11:38Marc Vasse: Very Honored to Have Been Invited to Moderate the Session "Haemostasis and Oncology'' at 25th Moroccan Days of Clinical Biology
-
Oct 5, 2025, 08:32Maria Elisa Mancuso: During Day 2 of the Annual EHC Conference We Discussed Very Rare Bleeding Disorders!
-
Oct 5, 2025, 08:21Mattia Galli Gives a Talk on Pharma Pulse About "De-escalation" of Antiplatelet Therapy in ACS
-
Oct 5, 2025, 07:56Rucha Patil: I Had An Opportunity to Deliver a Lecture on A Topic Close to My Heart at EHA 2025
-
Oct 4, 2025, 12:39Ahmed Abdalbagi - Drug Interactions Every Healthcare Professional Must Know
-
Oct 5, 2025, 12:43Nita Radhakrishnan and Colleagues on Tertiary Prophylaxis with Extended Half-life Factor in LMIC Settings
-
Oct 5, 2025, 12:15Laura Avila and Colleagues on Childhood DVT: Upper Extremity (UE) Post-thrombotic Syndrome (PTS)
-
Oct 5, 2025, 11:54Laura Girardi on Anticoagulant Treatment for Isolated Distal DVT: Finally Our Official Paper Is Out!
-
Oct 5, 2025, 08:11Nathan Connell: A Groundbreaking Study Has Just Been Published in Blood, From Vincent Muczynski and Colleagues
-
Oct 4, 2025, 12:38Andaleb Kholmukhamedov: Anticoagulation Management: Current Landscape And Future Trends
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 2, 2025, 04:572025 Innovators Award: Ile de France Région Recognizes 3 Researchers Who Have Committed Themselves to The Innovation
-
Oct 1, 2025, 15:59Anirban Sen Gupta: Thrilled to share a great collaboration story in Nature Portfolio
-
Oct 5, 2025, 12:29Miguel Crato: I Feel I Must Always Be Strong, But That Wears Me Down
-
Oct 5, 2025, 07:39Paige Bingham: ''Be data-driven'', "Don't jump to conclusions", "Be intentional''- Few Gems Shared During Impactful Close the Gap session at Transform AF
-
Oct 4, 2025, 10:21Maria Elisa Mancuso: Chance to Listen to Inspiring Experiences of People Who Live With Bleeding Disorders
-
Oct 4, 2025, 10:04Stéphanie Roullet Gave Talk on Platelet-Inspired Nanoparticles at SFTH 2025 Congress
-
Oct 4, 2025, 09:55NBDF: Proud to See Our Own Teri F Willey Representing the Foundation in the Funding Rare Disease Research Webinar